<?xml version="1.0" encoding="ISO-8859-15"?>








<rss version="2.0">
    <channel>
        
        <title>Valeant Pharmaceuticals International</title>
        <link>http://www.latimes.com/topic/economy-business-finance/valeant-pharmaceuticals-international-ORCRP016104.topic</link>
        
        
        <description>A collection of news and information related to Valeant Pharmaceuticals International published by Tribune Company sources.</description>
        
        <language>en-us</language>
        
        
			
			
				
					
					
					
					
		<item>
			<title><![CDATA[Valeant to buy contact-lens giant Bausch & Lomb for $4.5 billion]]></title>
			
			

			
			<link>http://www.latimes.com/topic/la-fi-mo-valeant-bausch-lomb-20130527,0,485251.story?track=rss-topicgallery</link>
				
			
			<pubDate>2013-05-27 12:50:00</pubDate>
            <description><![CDATA[Valeant Pharmaceuticals International Inc., Canada's largest publicly traded drug maker, is continuing an acquisition spree with an agreement to buy eye-care giant Bausch & Lomb Holdings Inc. for $4.5 billion. 

The Montreal company, which announced the...]]></description>
		</item>
				
					
					
					
					
		<item>
			<title><![CDATA[Teva Pharmaceutical offers $6.8 billion for Cephalon]]></title>
			
			

			
			<link>http://www.latimes.com/topic/la-fi-mo-valeant-bausch-lomb-20130527,0,485251.story?track=rss-topicgallery</link>
				
			
			<pubDate>2011-05-03 00:00:00</pubDate>
            <description><![CDATA[Valeant Pharmaceuticals International Inc., Canada's largest publicly traded drug maker, is continuing an acquisition spree with an agreement to buy eye-care giant Bausch & Lomb Holdings Inc. for $4.5 billion. 

The Montreal company, which announced the...]]></description>
		</item>
				
			
			
        

        
			
        
    </channel>
</rss>

